These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20042543)

  • 21. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
    J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma.
    Aoki S; Ikeda K; Yamamura M; Kojo S
    Biol Pharm Bull; 2001 Feb; 24(2):123-6. PubMed ID: 11217077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
    Pau E; He Y; Lougheed M; Steinbrecher UP
    Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy.
    Akdim F; Stroes ES; Sijbrands EJ; Tribble DL; Trip MD; Jukema JW; Flaim JD; Su J; Yu R; Baker BF; Wedel MK; Kastelein JJ
    J Am Coll Cardiol; 2010 Apr; 55(15):1611-8. PubMed ID: 20378080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells.
    Horie M; Hayashi M; Satoh T; Hotta H; Nagata Y; Ishida F; Kamei T
    Biochim Biophys Acta; 1993 May; 1168(1):45-51. PubMed ID: 8504141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia.
    Thomas T; Ginsberg H
    Curr Atheroscler Rep; 2010 Jan; 12(1):58-65. PubMed ID: 20425272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic regulation of apolipoprotein B.
    Avramoglu RK; Adeli K
    Rev Endocr Metab Disord; 2004 Dec; 5(4):293-301. PubMed ID: 15486461
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
    Wu X; Sakata N; Lui E; Ginsberg HN
    J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ethanol on hepatic apolipoprotein B synthesis and secretion in vitro.
    Wang TW; Byrne CD; Hales CN
    Biochim Biophys Acta; 1994 Mar; 1211(2):234-8. PubMed ID: 8117752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein synthesis in nonalcoholic steatohepatitis.
    Charlton M; Sreekumar R; Rasmussen D; Lindor K; Nair KS
    Hepatology; 2002 Apr; 35(4):898-904. PubMed ID: 11915037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
    Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
    Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octanoate reduces very low-density lipoprotein secretion by decreasing the synthesis of apolipoprotein B in primary cultures of chicken hepatocytes.
    Tachibana S; Sato K; Cho Y; Chiba T; Schneider WJ; Akiba Y
    Biochim Biophys Acta; 2005 Oct; 1737(1):36-43. PubMed ID: 16226916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein B synthesis: a square lattice model.
    Chen L; Zhang J; Chan L
    J Lipid Res; 1994 Jan; 35(1):84-92. PubMed ID: 8138725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
    Kaptein A; de Wit EC; Princen HM
    Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
    Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA editing: a novel mechanism for the regulation of dietary cholesterol absorption.
    Scott J
    Trans Med Soc Lond; 1989-1990; 106():51-9. PubMed ID: 2562621
    [No Abstract]   [Full Text] [Related]  

  • 38. Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia.
    Black DD; Hay RV; Rohwer-Nutter PL; Ellinas H; Stephens JK; Sherman H; Teng BB; Whitington PF; Davidson NO
    Gastroenterology; 1991 Aug; 101(2):520-8. PubMed ID: 2065927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic.
    Bass NM
    Hepatology; 2010 Jan; 51(1):4-7. PubMed ID: 20034031
    [No Abstract]   [Full Text] [Related]  

  • 40. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
    Koizumi J; Mabuchi H; Takeda R; Okamoto H
    Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.